Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 15.50
+0.34 (2.24%)
Apr 1, 2026, 5:30 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 322.31 million as of April 1, 2026. Its market cap has increased by 95.03% in one year.
Market Cap
322.31M
Enterprise Value
330.96M
Revenue
17.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.50
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 322.31M, an increase of 4.29%. That is a compound annual growth rate of 0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 315.24M | -33.78% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 872.73M |
| Basilea Pharmaceutica AG | 668.66M |
| Santhera Pharmaceuticals Holding AG | 216.70M |
| BioVersys AG | 166.67M |
| Xlife Sciences AG | 115.35M |
| Molecular Partners AG | 114.11M |
| EvoNext Holdings | 6.56M |
| Addex Therapeutics | 4.66M |